Not medical advice. Talk to your provider before using any peptide.
Full disclaimerImmune Support Protocols
Peptide Schedule Research Team
Immune modulation protocols using thymic peptides for T-cell support and immune balance.
Immune peptide protocols target adaptive immunity through thymic peptide supplementation. Thymosin Alpha-1 (TA-1) is the most studied, with over 30 clinical trials and 11,000+ participants demonstrating immune modulation effects.
TA-1 activates dendritic cells via TLR2/TLR9 signaling, promoting T-cell maturation and NK cell activity. It is used in hepatitis, cancer immunotherapy, and general immune optimization contexts. LL-37 provides antimicrobial defense through direct membrane disruption of pathogens.
These protocols are typically run for defined courses (2-4 weeks) rather than continuously, with dosing 2-3 times per week. TA-1 is well-tolerated with minimal side effects at standard doses.